###begin article-title 0
Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway
###end article-title 0
###begin p 1
A. Espinosa, V. Dardalhon, and S. Brauner contributed equally to this paper.
###end p 1
###begin p 2
###xml 355 358 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 432 435 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1128 1131 1128 1131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
###xml 1132 1136 <span type="species:ncbi:10090">mice</span>
Ro52/Trim21 is targeted as an autoantigen in systemic lupus erythematosus and Sjogren's syndrome. Polymorphisms in the Ro52 gene have been linked to these autoimmune conditions, but the molecular mechanism by which Ro52 may promote development of systemic autoimmune diseases has not been explored. To address this issue, we generated Ro52-null mice (Ro52-/-), which appear phenotypically normal if left unmanipulated. However, Ro52-/- mice develop severe dermatitis extending from the site of tissue injury induced by ear tags. The affected mice further develop several signs of systemic lupus with hypergammaglobulinemia, autoantibodies to DNA, proteinuria, and kidney pathology. Ro52, which was recently identified as an E3 ligase, mediates ubiquitination of several members of the interferon regulatory factor (IRF) family, and the Ro52-deficient mice have an enhanced production of proinflammatory cytokines that are regulated by the IRF transcription factors, including cytokines involved in the Th17 pathway (interleukin [IL] 6, IL-12/IL-23p40, and IL-17). Loss of IL-23/IL-17 by genetic deletion of IL-23/p19 in the Ro52-/- mice conferred protection from skin disease and systemic autoimmunity. These data reveal that the lupus-associated Ro52 protein is an important negative regulator of proinflammatory cytokine production, and they provide a mechanism by which a defective Ro52 function can lead to tissue inflammation and systemic autoimmunity through the IL-23-Th17 pathway.
###end p 2
###begin p 3
###xml 485 506 481 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Borchers et al., 2003</xref>
###xml 508 536 504 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Ramanujam and Davidson, 2008</xref>
###xml 648 671 644 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Sigurdsson et al., 2005</xref>
###xml 673 692 669 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Graham et al., 2006</xref>
###xml 694 715 690 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Nordmark et al., 2009</xref>
Systemic lupus erythematosus (SLE) and Sjogren's syndrome are related and partly overlapping autoimmune diseases that share several genetic and phenotypic features. SLE represents a more severe systemic autoimmune condition, but both diseases may involve multiple organs including skin, muscle, joints, and vital internal organs such as kidneys. Both disorders present with activation of type 1 IFN pathways, with increased levels of the cytokines IL-6, IL-12/IL-23p40, and TNF-alpha (Borchers et al., 2003; Ramanujam and Davidson, 2008), and both conditions have a genetic association with polymorphisms in the IFN regulatory factor (IRF) 5 gene (Sigurdsson et al., 2005; Graham et al., 2006; Nordmark et al., 2009).
###end p 3
###begin p 4
###xml 223 243 223 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Reymond et al., 2001</xref>
###xml 245 264 245 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Hennig et al., 2005</xref>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">2008</xref>
###xml 272 293 272 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Ottosson et al., 2006</xref>
###xml 377 398 377 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Espinosa et al., 2006</xref>
###xml 458 475 458 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Kong et al., 2007</xref>
###xml 477 495 477 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Higgs et al., 2008</xref>
###xml 613 631 613 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Frank et al., 1993</xref>
###xml 633 652 633 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Nakken et al., 2001</xref>
###xml 929 933 <span type="species:ncbi:10090">mice</span>
Ro52 is a target autoantigen in several systemic autoimmune diseases, including SLE and Sjogren's syndrome, and molecular characterization of Ro52 revealed that it belongs to the TRIM (Tripartite motif) family of proteins (Reymond et al., 2001; Hennig et al., 2005, 2008; Ottosson et al., 2006). Like several members of this family, Ro52 has RING-dependent E3 ligase activity (Espinosa et al., 2006) and has been suggested to polyubiquitinate IRF3 and IRF8 (Kong et al., 2007; Higgs et al., 2008). Although genetic polymorphisms in the Ro52 gene have been linked to the development of SLE and Sjogren's syndrome (Frank et al., 1993; Nakken et al., 2001), it has not been addressed how Ro52 regulates cytokine production, tissue inflammation, and development of systemic autoimmunity. To investigate the molecular mechanisms that may link Ro52 to the development of systemic autoimmunity, we generated Ro52-deficient GFP-reporter mice.
###end p 4
###begin title 5
RESULTS AND DISCUSSION
###end title 5
###begin title 6
Ro52 is an immune-specific gene induced by IFNs
###end title 6
###begin p 7
###xml 173 184 173 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1, A&#8211;C</xref>
###xml 532 540 532 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 1049 1050 1049 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1060 1061 1060 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1065 1066 1065 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1074 1082 1074 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 E</xref>
###xml 1177 1196 1177 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Rhodes et al., 2002</xref>
###xml 1198 1221 1198 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Strandberg et al., 2008</xref>
###xml 1324 1332 1313 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 F</xref>
###xml 1414 1422 1396 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 F</xref>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 765 771 <span type="species:ncbi:9606">humans</span>
We inserted an IRES-GFP reporter cassette into the Ro52 locus to generate Ro52-deficient mice in which the GFP expression allowed us to track Ro52-expressing cells in vivo (Fig. 1, A-C). Tissue specificity of Ro52 expression has not been investigated systematically, and using GFP as a reporter for Ro52 expression, we observed that Ro52 was predominantly expressed in the lymphoid compartments of spleen, lymph node, and thymus, with little or no expression in nonimmune tissues including liver, pancreas, heart, kidney, and skin (Fig. 1 D and ). Some expression was observed in endothelial cells (Fig. S1). Our findings are supported by microarray analysis, showing that Ro52 messenger RNA is predominantly expressed in lymphoid cell populations in both mice and humans (). These observations suggest that the primary function of Ro52 may be in the immune system. The vast majority of leukocytes in the bone marrow, thymus, spleen, lymph nodes, and peripheral blood expressed Ro52, as detected by GFP expression, with the highest expression in CD3+ and CD11b+GR-1+ cells (Fig. 1 E and not depicted). Using GFP as the reporter, we noted that, as has previously been reported (Rhodes et al., 2002; Strandberg et al., 2008), the expression of Ro52 was induced by IFN-gamma and, to a lesser extent, by IFN-alpha and IFN-beta (Fig. 1 F). Other cytokines (TGF-beta or TNF-alpha) did not affect the expression of Ro52 (Fig. 1 F).
###end p 7
###begin p 8
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ro52 is expressed in the immune system and induced by IFNs.</bold>
###xml 103 106 103 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 290 293 290 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 303 306 303 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 459 462 459 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 471 474 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 672 675 672 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1032 1035 1028 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1317 1320 1313 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1446 1449 1442 1445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
###xml 1179 1183 <span type="species:ncbi:10090">mice</span>
###xml 1321 1325 <span type="species:ncbi:10090">mice</span>
###xml 1450 1454 <span type="species:ncbi:10090">mice</span>
Ro52 is expressed in the immune system and induced by IFNs. (A) Targeting construct for generating Ro52-/- mice. Primer pairs "a" and "b" were used for genotyping WT and targeted allele, respectively. (B) Genotyping PCR for WT (340 bp) and Ro52-null (700 bp) alleles by PCR in Ro52+/+, Ro52+/-, and Ro52-/- mice. (C) Immunoblotting for Ro52 and GFP expression in splenocyte cell extracts demonstrates loss of Ro52 expression and gain of GFP expression in Ro52+/- and Ro52-/- mice. Data are representative for three independent experiments. (D) Ro52 is specifically expressed in immune tissues as shown by GFP expression (brown) in organ sections (five per organ) from Ro52+/- mice investigated by immunohistochemistry using an anti-GFP antibody. Slides were counterstained with hematoxylin. Data are representative of five independent mice and represent one of two experimental repeats. The original magnification was 10x. Bar, 100 microm. (E) Ro52 is expressed in all major leukocyte populations, as shown by GFP expression in Ro52+/- splenocytes using flow cytometry. The numbers in the quadrants represent the percentage of cells in each quadrant and are representative of 12 mice analyzed in four independent experiments. (F) Ro52 is induced by type I and II IFNs. GFP expression in cells from bone marrow of Ro52+/- mice cultured for 24 h with medium (gray line) or medium + cytokine (black line). Filled histogram represents cells from Ro52+/+ mice. Data are representative of three independent experiments.
###end p 8
###begin p 9
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 202 205 202 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 493 496 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 502 505 502 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 515 518 515 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 553 554 553 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 570 573 570 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 651 654 651 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 771 774 771 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 775 779 <span type="species:ncbi:10090">mice</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
Ro52-/- mice were born at a slightly reduced Mendelian ratio (Ro52+/+, 27%; Ro52+/-, 51%; Ro52-/-, 22%; P = 0.0001 at n = 280, Chi-Square test) without affecting the male/female ratio. However, the Ro52-/- mice that were born appeared normal and had no detectable abnormalities in organ morphology or histology. Specifically, we did not observe any differences in the size or organization in spleen, thymus, and lymph nodes or in subsets of immune cells when comparing young unmanipulated Ro52+/+, Ro52+/-, and Ro52-/- mice ( and ). However, splenic CD3+ T cells of Ro52-/- mice had an increased frequency of T cells with an activated phenotype (CD62Llow; Fig. S3). These data indicate that although there are discreet signs of early activation in splenic T cells in Ro52-/- mice, there is no apparent immune phenotype or other physical abnormalities present in naive unmanipulated Ro52-deficient mice.
###end p 9
###begin title 10
Ro52 deficiency leads to tissue inflammation and systemic autoimmunity
###end title 10
###begin p 11
###xml 283 286 283 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 405 408 405 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 425 436 425 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, A-C</xref>
###xml 472 475 472 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 707 715 707 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 785 788 785 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 811 819 811 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
###xml 1000 1008 1000 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 E</xref>
###xml 1204 1212 1204 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 F</xref>
###xml 1381 1384 1381 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1629 1632 1629 1632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
###xml 1038 1042 <span type="species:ncbi:10090">mice</span>
###xml 1344 1348 <span type="species:ncbi:10090">mice</span>
###xml 1385 1389 <span type="species:ncbi:10090">mice</span>
###xml 1633 1637 <span type="species:ncbi:10090">mice</span>
Individual mice are routinely identified either by ear punching or by metallic ear tags. After ear tagging with metal clips, no visible tissue reaction, other than transient erythema and swelling, is normally observed. However, 25 wk after application of metal ear tags, >90% of Ro52-/- mice had developed a very severe and progressive dermatitis emanating from the tagged ear, which did not occur in Ro52+/+ WT littermates (Fig. 2, A-C). Dermatitis also developed in Ro52+/- mice but was not present in Ro52-deficient mice that had lost their ear tag. Histological analysis of the skin lesions showed epidermal hyperplasia with ulcerations and inflammatory infiltrates consisting primarily of neutrophils (Fig. 2 B). Serum immunoglobulin analysis revealed increased IgG levels in Ro52-/- mice with dermatitis (Fig. 2 D), and the affected mice also developed antinuclear antibodies (ANAs), with specificity for DNA, and autoantibodies to several lupus-associated autoantigens and other autoantigens (Fig. 2 E and ). Furthermore, affected mice developed kidney pathology with substantiated mesangium and intraglomerular immunoglobulin depositions, as well as proteinuria, showing impaired renal function (Fig. 2 F). The systemic nature of the inflammation was further supported by the development of splenomegaly and lymphadenopathy in affected mice (Fig. S4 and not depicted). Ro52-/- mice that were not ear tagged did not develop either dermatitis or systemic autoimmunity when observed up to 40 wk of age, suggesting that initial tissue injury induced by physical ear tagging results in uncontrolled tissue inflammation in Ro52-/- mice and, subsequently, leads to development of systemic autoimmunity.
###end p 11
###begin p 12
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ro52-deficient mice develop tissue inflammation and systemic autoimmunity.</bold>
###xml 299 302 299 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 311 314 311 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 428 431 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 482 485 478 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 499 500 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 623 626 619 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 772 775 768 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 798 799 794 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 813 816 809 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 823 824 819 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 857 858 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 922 925 916 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1185 1188 1179 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1190 1191 1184 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1205 1208 1199 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1210 1211 1204 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1244 1245 1236 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 1439 1442 1427 1430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1633 1636 1617 1620 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1638 1639 1622 1623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1665 1668 1649 1652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1675 1676 1659 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1708 1709 1690 1691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 1813 1816 1791 1794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1856 1859 1834 1837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 2018 2021 1996 1999 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2035 2038 2013 2016 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 2388 2391 2354 2357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2436 2439 2402 2405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 776 780 <span type="species:ncbi:10090">mice</span>
###xml 817 821 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
###xml 1160 1164 <span type="species:ncbi:10090">mice</span>
###xml 1443 1447 <span type="species:ncbi:10090">mice</span>
###xml 1608 1612 <span type="species:ncbi:10090">mice</span>
###xml 1669 1673 <span type="species:ncbi:10090">mice</span>
###xml 1817 1821 <span type="species:ncbi:10090">mice</span>
###xml 2039 2043 <span type="species:ncbi:10090">mice</span>
###xml 2392 2397 <span type="species:ncbi:10090">mouse</span>
###xml 2440 2445 <span type="species:ncbi:10090">mouse</span>
Ro52-deficient mice develop tissue inflammation and systemic autoimmunity. (A) Photographs of the progressive dermatitis developing spontaneously from tissue injury mediated by ear tags in Ro52-deficient mice. Metal tag length, 1 cm. (B) Histology with Toluidine blue staining of ears of tagged Ro52+/+ and Ro52-/- mice. Bars, 150 microm. A and B are representative of mice in C. (C) Incidence of dermatitis. 13 independent Ro52-/- mice born during a period of 1.5 yr and their Ro52+/+ littermates (n = 11) were followed for dermatitis development. Dermatitis developed at different ages but, eventually, in all tagged Ro52-/- mice, whereas none of their littermate controls developed the disease. (D) Serum immunoglobulin levels determined by ELISA in triplicates in Ro52-/- mice with dermatitis (n = 6) and Ro52+/+ mice (n = 12; mean+/- SEM; Mann-Whitney U test). Data represent one of two experimental repeats. (E) Ro52-/- mice with dermatitis develop ANA. Presence of ANA was tested by immunofluorescence of Hep-2 cells and summarized as the percent positive in each group, and anti-DNA antibody levels were measured by ELISA (triplicates) in ANA-positive mice with dermatitis Ro52-/- (n = 5) and Ro52+/+ (n = 16; Mean+/- SEM; Mann-Whitney U test). Data represent one of two experimental repeats. Bar, 75 microm. (F, top) Electron microscopy photographs of renal glomeruli with increased mesangium and immunoglobulin deposition in Ro52-/- mice indicated by arrows. Bar, 2 microm. (F, bottom) Immunofluorescence IgG staining of renal glomeruli visualizing deposited IgG (red) and proteinuria (g/liter) in mice with dermatitis Ro52-/- (n = 7) and age-matched Ro52+/+ mice (n = 8; mean+/- SEM; Mann-Whitney U test). Bar, 10 microm. (G) Increased cytokine expression in draining lymph node cells ex vivo from Ro52-/- mice with dermatitis compared with Ro52+/+ littermates. Cytokine expression was investigated by quantitative RT-PCR in triplicates and calculated relative to HPRT. Data are representative for five Ro52-/- and five Ro52+/+ mice analyzed in five independent experiments and each assay was performed at least twice. (H) Cytokine production in triplicate supernatants was measured by ELISA after culture of cells from draining lymph nodes with 1 microg/ml anti-CD3 (IFN-gamma, IL-4, and IL-17) or 1 microg/ml LPS (IL-12/IL-23p40) for 48 h. Data are representative of one Ro52-/- mouse with dermatitis compared with one Ro52+/+ mouse in eight independent experiments. Assays were performed at least twice. (I) Cells producing IL-17 were determined by intracellular cytokine staining and flow cytometry of cells from draining lymph nodes after in vitro culture with anti-CD3 for 48 h followed by restimulation with PMA/ionomycin for 4 h. One out of three independent experiments is shown. Numbers in quadrants represent the percentage of cells in each.
###end p 12
###begin p 13
###xml 270 271 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 275 276 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 345 346 345 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 362 363 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 643 658 643 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, G and H</xref>
###xml 713 728 713 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, G and H</xref>
###xml 790 793 786 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 821 824 817 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 831 839 827 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 H</xref>
###xml 884 885 880 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 893 901 889 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 I</xref>
###xml 954 957 950 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1117 1120 1113 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
###xml 1121 1125 <span type="species:ncbi:10090">mice</span>
To elucidate the cellular mechanism causing tissue inflammation and systemic autoimmunity in Ro52-deficient mice, we analyzed draining lymph node cells and splenocytes from the affected animals for phenotypic and functional changes. There was a marked expansion of CD11b+GR-1+ cells in both spleen and lymph nodes, there was an expansion of CD19+ B cells and CD3+ T cells in the lymph nodes, and the T cells had attained an activated phenotype in the affected mice (Fig. S4). Furthermore, lymph node and spleen cells from affected mice hyperproliferated spontaneously (not depicted) and produced IL-6, IL-12/IL-23p40, IL-21, IL-22, and IL-17 (Fig. 2, G and H), which was further increased upon T cell activation (Fig. 2, G and H). IL-4 and IFN-gamma production was not increased in the Ro52-/- mice compared with the Ro52+/+ mice (Fig. 2 H). IL-17 in affected mice was produced by CD4+ cells (Fig. 2 I), indicating that Th17 cells are induced in the Ro52-/- mice after skin inflammation. The increased production of IL-17 also begins to explain why dermal lesions are predominantly composed of neutrophils in the Ro52-/- mice, as IL-17 recruits and activates these cells.
###end p 13
###begin title 14
###xml 83 87 <span type="species:ncbi:10090">mice</span>
High levels of proinflammatory cytokines after immune activation in Ro52-deficient mice
###end title 14
###begin p 15
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 284 287 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 324 332 324 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 454 462 454 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 542 545 542 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 634 642 634 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 805 813 801 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 877 880 869 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 913 914 905 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 939 947 931 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">Mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 881 885 <span type="species:ncbi:10090">mice</span>
To further study the hyperresponsive immune system of Ro52-/- mice in a more controlled manner, we tested the response in Ro52-/- mice to low doses of the contact-sensitizing agent Oxazolone. Mice lacking Ro52 had a significantly higher contact hypersensitivity to Oxazolone than Ro52+/+ mice, as measured by ear thickness (Fig. 3 A), with affected ears showing epidermal hyperplasia and inflammatory infiltrates consisting predominantly of neutrophils (Fig. 3 B). Analysis of lymphoid cell populations in the draining lymph nodes of the Ro52-/- mice treated with Oxazolone showed accumulation of T cells with an activated phenotype (Fig. 3 C) and production of high amounts of the proinflammatory cytokines IL-6, IL-12/IL-23p40, TNF-alpha, and IL-17 and IL-23R expression after application of Oxazolone (Fig. 3 D). Production of IFN-gamma was not different between WT and Ro52-/- mice, and the frequency of FoxP3+ cells was not affected (Fig. 3 D). These data demonstrate that a lack of Ro52 leads to dysregulated tissue inflammation with enhanced generation of effector T cells that produce proinflammatory cytokines.
###end p 15
###begin p 16
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Increased tissue inflammation in Ro52<sup>&#8722;/&#8722;</sup> mice.</bold>
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 488 491 480 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 505 508 497 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 616 619 608 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 633 636 625 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
Increased tissue inflammation in Ro52-/- mice. (A) Increased ear thickness in Ro52-/- (n = 5) compared with Ro52+/+ (n = 5) mice after Oxazolone challenge. (ANOVA mixed model). (B) Microphotographs of treated ears. Original magnification, 10x. Bars, 100 microm. (C) Flow cytometry analysis of draining lymph node cells in mice from A. (D) Cytokines in triplicate supernatants of cultures after in vitro stimulation with 1 microg/ml anti-CD3 of cells from draining lymph nodes of five Ro52-/- and five Ro52+/+ mice analyzed by ELISA. IL-23R and FoxP3 expression in cells derived from draining lymph nodes of five Ro52-/- and five Ro52+/+ mice was analyzed by RT-PCR and calculated relative to HPRT. Data in A-D are representative of three independent experiments. Error bars represent SEM.
###end p 16
###begin title 17
Ro52 is a negative-feedback regulator of proinflammatory cytokine expression
###end title 17
###begin p 18
###xml 270 287 270 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Kong et al., 2007</xref>
###xml 289 307 289 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Higgs et al., 2008</xref>
###xml 498 501 494 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 756 764 752 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 910 918 906 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
To understand the mechanism by which a deficiency in the Ro52 E3 ligase leads to increased cytokine production and tissue inflammation, we aimed to identify substrates ubiquitinated by Ro52. IRF8 and IRF3 have been suggested as targets for Ro52-mediated ubiquitination (Kong et al., 2007; Higgs et al., 2008). However, as there is a genetic linkage with IRF5 polymorphisms to SLE and Sjogren's syndrome, and proinflammatory cytokines IL-12/IL-23p40, IL-6, and TNF-alpha, which are increased in Ro52-/- mice, are also regulated by IRF5, we hypothesized that IRF5 may be a substrate for Ro52. Using in vivo ubiquitination assays, we confirmed that IRF3 and IRF8 are polyubiquitinated by Ro52 and, in addition, we observed polyubiquitination of IRF5 by Ro52 (Fig. 4 A). SMAD4, which has structural homology to the IRF proteins, was used as a negative control in our experiments and was not ubiquitinated by Ro52 (Fig. 4 A).
###end p 18
###begin p 19
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ro52 inhibits IRF activity and regulates proinflammatory cytokine expression.</bold>
###xml 1043 1046 1043 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1048 1049 1048 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1073 1076 1073 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1078 1079 1078 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1212 1213 1204 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1085 1089 <span type="species:ncbi:10090">mice</span>
Ro52 inhibits IRF activity and regulates proinflammatory cytokine expression. (A) Immunoblotting of immunoprecipitates from transfected 293T cells show Ro52-mediated polyubiquitination of IRF3, IRF8, and IRF5 but not SMAD4. FLAG-IRFs and Ro52-GFP were detected in whole cell lysates. Data are representative of three independent experiments. Black lines indicate that intervening lanes have been spliced out. (B) The effect of Ro52 on IRF3 and IRF5 activity was investigated in polyI:C-stimulated TLR3 293T transfectants (IRF3) or CpG-stimulated TLR9 293T transfectants (IRF5) using a GAL4 one-hybrid luciferase reporter assay. GAL4-IRF3- and GAL4-IRF5-mediated luciferase expression was diminished by the simultaneous coexpression of Ro52 as compared with an empty vector control (EV), indicating that Ro52 inhibits the activity of IRF3 and IRF5. A representative experiment out of three independent experiments is shown. RLU, relative luciferase units. (C) Increased proinflammatory cytokine production in splenocytes derived from naive Ro52-/- (n = 5) compared with Ro52+/+ (n = 5) mice. Splenocytes were cultured with 2 microg/ml CpG and 100 U/ml IFN-gamma or UV-inactivated herpes simplex virus (HSV; 2 x 106 PFU/ml), followed by cytokine measures in supernatants (triplicates) by ELISA or DELFIA (IFN-alpha and IFN-beta). Data are representative of three independent experiments. Error bars represent SEM.
###end p 19
###begin p 20
###xml 494 502 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 774 777 763 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 925 928 914 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1109 1112 1087 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1120 1128 1098 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 1319 1325 1297 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig.1F</xref>
To directly investigate the effects of Ro52 on the transcriptional activity of IRFs, we used a GAL4 one-hybrid luciferase reporter approach. IRF3 and IRF5 fused to GAL4 were tested for their ability to drive luciferase expression from a 4xGAL4-luciferase reporter plasmid upon transfection into 293T cells. Cotransfection with Ro52 substantially decreased IRF3 and IRF5 transcriptional activity in response to toll-like receptor (TLR) 3 or TLR9 signaling induced by polyI:C or CpG stimulation (Fig. 4 B). These findings indicate that a deficiency in Ro52 would lead to increased IRF activity in vivo and persistent production of cytokines induced by IRF3 and 5, such as IL-6, TNF-alpha, IFN-alpha, IFN-beta, and IL-12/IL-23p40. To investigate the cytokine production in Ro52-/- cells after TLR stimulation, the knockout cells were cultured with TLR agonists including CpG, LPS, polyI:C, and Imiquimod. The stimulation of Ro52-/- splenocytes or bone marrow-derived macrophages resulted in increased expression of cytokines (IL-6, TNF-alpha, IFN-alpha, IFN-beta, IL-12/IL-23p40, and IL-23p19) compared with Ro52+/+ cells (Fig. 4 C and not depicted), confirming that the loss of Ro52 indeed leads to increased expression of many proinflammatory cytokines. Together, our data show that IFNs will induce expression of Ro52 (Fig.1F) and that Ro52, in turn, will suppress expression of the proinflammatory cytokines IL-6, TNF-alpha, IFN-alpha, IFN-beta, and IL-12/IL-23p40 through ubiquitination of IRF3, 5, and 8. Thus, the cellular role of the IFN-induced Ro52 is to act as a negative-feedback regulator of immune responses and inflammation by suppressing the expression of IRF-induced proinflammatory cytokines.
###end p 20
###begin title 21
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Disruption of the IL-23-Th17 pathway inhibits tissue inflammation and systemic autoimmunity in Ro52-/- mice
###end title 21
###begin p 22
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 238 254 238 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Cua et al., 2003</xref>
###xml 256 277 256 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Bettelli et al., 2006</xref>
###xml 364 384 364 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Crispin et al., 2008</xref>
###xml 386 405 386 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Nguyen et al., 2008</xref>
###xml 611 614 607 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 664 667 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 686 689 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 822 825 818 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 894 897 890 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 928 943 924 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, A and B</xref>
###xml 993 996 989 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1049 1057 1045 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 1181 1184 1173 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1233 1236 1225 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1239 1242 1231 1234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1249 1257 1241 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 D</xref>
###xml 1324 1327 1316 1319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1367 1370 1359 1362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1373 1376 1365 1368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1415 1430 1407 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, E and F</xref>
###xml 1441 1444 1433 1436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1447 1450 1439 1442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1562 1565 1554 1557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1572 1587 1564 1579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, G and H</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 364 371 <span type="species:ncbi:300214">Crispin</span>
###xml 615 619 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
###xml 898 902 <span type="species:ncbi:10090">mice</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1043 1047 <span type="species:ncbi:10090">mice</span>
###xml 1185 1189 <span type="species:ncbi:10090">mice</span>
###xml 1243 1247 <span type="species:ncbi:10090">mice</span>
###xml 1328 1332 <span type="species:ncbi:10090">mice</span>
###xml 1451 1455 <span type="species:ncbi:10090">mice</span>
###xml 1566 1570 <span type="species:ncbi:10090">mice</span>
###xml 1749 1753 <span type="species:ncbi:10090">mice</span>
Ro52-/- mice developing dermatitis and systemic autoimmunity produced IL-6 and IL-12/IL-23p40 and had increased levels of Th17 cells in the draining lymph nodes. IL-6 and IL-23 are needed for differentiation and maturation of Th17 cells (Cua et al., 2003; Bettelli et al., 2006), and the IL-23-IL-17 axis appears to be hyperactive in lupus and Sjogren's syndrome (Crispin et al., 2008; Nguyen et al., 2008). We therefore hypothesized that genetic disruption of the IL-23-Th17 pathway rather than the IL-12-IFN-gamma pathway would result in inhibition of the tissue inflammation and systemic autoimmunity in Ro52-/- mice. To address this hypothesis, we crossed Ro52-/- mice with IL-23p19-/- mice to disrupt the IL-23-Th17 pathway. The increased hypersensitivity with dermatitis and inflammatory infiltrates observed in Ro52-/- mice after Oxazolone application was completely reversed in the Ro52-/- mice lacking IL-23p19 chains (Fig. 5, A and B). The enhanced T cell activation observed in Ro52-/- mice was also reversed in the double knockout mice (Fig. 5 C). In addition, the increased expression of IL-23R, IL-12/IL-23p40, IL-17, and RoRgammat in the draining lymph nodes of Ro52-/- mice was reversed to baseline levels in the Ro52-/-p19-/- mice (Fig. 5 D). Furthermore, the skin inflammation after ear tagging in the Ro52-/- mice did not develop in ear-tagged Ro52-/-p19-/- in up to 6 mo (30 wk) of observation (Fig. 5, E and F). The Ro52-/-p19-/- mice did not develop ANA or anti-DNA antibodies and did not develop kidney pathology as did the ear-tagged Ro52-/- mice (Fig. 5, G and H). Together, these data demonstrate that abrogating the IL-23-Th17 pathway abolishes tissue inflammation and systemic autoimmunity observed in the Ro52-deficient mice after ear tagging and Oxazolone treatment.
###end p 22
###begin p 23
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ro52<sup>&#8722;/&#8722;</sup> related tissue inflammation is dependent on the IL-23&#8211;IL-17 pathway.</bold>
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 154 157 154 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 169 172 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 176 179 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 181 182 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 192 195 192 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 203 204 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 450 453 446 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 456 459 452 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 461 462 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 472 475 468 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 478 481 474 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 483 484 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 615 618 611 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 621 624 617 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 626 627 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 637 640 633 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 643 646 639 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 648 649 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 659 662 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 665 668 661 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 670 671 666 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 802 805 798 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 808 811 804 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 830 833 826 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 836 839 832 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 893 896 889 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 899 902 895 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 908 911 904 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 914 917 910 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1062 1065 1058 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1068 1071 1064 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1362 1365 1358 1361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1369 1372 1365 1368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1374 1375 1370 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1386 1389 1382 1385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1392 1395 1388 1391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1397 1398 1393 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1414 1417 1410 1413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1420 1423 1416 1419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1425 1426 1421 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1459 1460 1453 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 1575 1578 1565 1568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1581 1584 1571 1574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 771 775 <span type="species:ncbi:10090">Mice</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
###xml 1072 1077 <span type="species:ncbi:10090">mouse</span>
###xml 1144 1148 <span type="species:ncbi:10090">mice</span>
###xml 1585 1589 <span type="species:ncbi:10090">mice</span>
###xml 1604 1608 <span type="species:ncbi:10090">mice</span>
Ro52-/- related tissue inflammation is dependent on the IL-23-IL-17 pathway. (A) Ear thickness after Oxazolone challenge. Ro52-/-p19+/+, n = 5; Ro52-/-p19-/-, n = 5; p19-/-Ro52+/+, n = 3; Ro52+/+p19+/+, n = 3 (ANOVA mixed model). (B) Microphotographs of Oxazolone-treated ears. Ears of all mice in A were analyzed. Original magnification, 10x. Bars, 100 microm. (C) Flow cytometry analysis of draining lymph node cells of Oxazolone-treated mice (Ro52-/-p19+/+, n = 5; Ro52-/-p19-/-, n = 5). (D) Cytokine expression in cells from draining lymph nodes ex vivo measured by RT-PCR with expression relative to HPRT (Ro52-/-p19+/+, n = 5; Ro52-/-p19-/-, n = 5; Ro52+/+p19+/+, n = 3). Data in A-D depicts one out of two representative experiments. Error bars represent SEM. (E) Mice without dermatitis in Ro52-/-p19+/+ compared with Ro52-/-p19-/- mice. Number of mice observed at different ages (Ro52-/-p19+/+; Ro52-/-p19-/-): 5 wk (11; 21), 10 wk (11; 18), 15 wk (11; 14), 20 wk (11; 6), 25 wk (11; 5), and 30 wk (11; 4; Fischer's exact test). (F) Ear with tag in Ro52-/-p19-/- mouse showing no inflammation or dermatitis. Data are representative of mice in E. Metal tag length, 1 cm. (G) ANA analysis tested by immunofluorescence of Hep-2 cells and summarized as the percent positive in each group, and anti-DNA antibody levels measured by ELISA (triplicates) in Ro52-/- p19+/+ (n = 7), Ro52-/-p19-/- (n = 10), and Ro52+/+p19+/+ (n = 7; mean +/- SEM; Mann-Whitney U test). Bar, 50 microm. (H) Electron microscopy image of kidneys depicting reversal of pathological changes in Ro52-/-p19-/- mice (arrows). All mice in A were analyzed. Bar, 2 microm.
###end p 23
###begin p 24
###xml 168 187 168 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Rhodes et al., 2002</xref>
###xml 189 212 189 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Strandberg et al., 2008</xref>
###xml 502 521 491 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Kim and Ozato, 2009</xref>
###xml 523 540 512 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Yang et al., 2009</xref>
###xml 774 792 763 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Higgs et al., 2008</xref>
###xml 794 813 783 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Kim and Ozato, 2009</xref>
###xml 1050 1073 1039 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Strandberg et al., 2008</xref>
###xml 1252 1273 1241 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Espinosa et al., 2008</xref>
###xml 1283 1286 1272 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1886 1907 1875 1896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Baechler et al., 2004</xref>
###xml 1909 1930 1898 1919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Ronnblom et al., 2006</xref>
###xml 1287 1291 <span type="species:ncbi:10090">mice</span>
###xml 1349 1353 <span type="species:ncbi:10090">mice</span>
###xml 1960 1964 <span type="species:ncbi:10090">mice</span>
###xml 2053 2057 <span type="species:ncbi:10090">mice</span>
###xml 2347 2352 <span type="species:ncbi:9606">human</span>
###xml 2501 2509 <span type="species:ncbi:9606">patients</span>
In summary, our studies demonstrate that Ro52 is a key negative regulator of inflammation. Although expressed at a steady-state level, Ro52 is further induced by IFNs (Rhodes et al., 2002; Strandberg et al., 2008), and our data show that Ro52 then acts to control and down-regulate the proinflammatory cytokines IL-6, TNF-alpha, IFN-alpha, IFN-beta, and IL-12/IL-23p40, thus providing a negative-feedback loop by suppressing IFN-mediated immune activation. Recent studies indicate dual roles for Ro52 (Kim and Ozato, 2009; Yang et al., 2009) and indicate that this E3 ligase may act to sustain IRF3 and IRF8 stability under some conditions but may promote polyubiquitination and degradation of the same transcription factors after TLR- and IFN-mediated activation of cells (Higgs et al., 2008; Kim and Ozato, 2009). Different functions for Ro52 depending on the degree of cellular activation is consistent with our previous observations that Ro52 resides in the cytoplasm in unstimulated cells but translocates into the nucleus upon IFN stimulation (Strandberg et al., 2008) and that Ro52-mediated ubiquitination is supported both by UbcH5 and UbcH6 ubiquitin-conjugating enzymes/E2 ligases that are present in the cytoplasm and nucleus, respectively (Espinosa et al., 2008). In Ro52-/- mice, we observed no obvious phenotype in naive unmanipulated mice, but we did observe a severe unrelenting tissue inflammation after tissue injury, progressing into systemic autoimmunity with several lupus-like features, which was dependent on the IL-23-IL-17 pathway, stressing the importance of Ro52 as a negative regulator of inflammatory responses. Our data begin to build an understanding of how loss or genetic deficiency of Ro52 would result in dysregulation of IFN pathways, a feature which is common to many systemic autoimmune diseases as they present clinically with an "IFN signature" (Baechler et al., 2004; Ronnblom et al., 2006). The Ro52 haploinsufficient mice developed disease at the same frequency and with similar phenotypical expression as the mice that completely lacked Ro52, suggesting an important role of Ro52 in regulating immune homeostasis and that even a partial loss of function for this key regulatory protein would result in exaggerated tissue inflammation and systemic autoimmunity. From our data, one would predict that the human genetic linkage to polymorphisms in the Ro52 gene most likely relate to reduction in the level, binding, or function of Ro52 in systemic autoimmune patients.
###end p 24
###begin p 25
###xml 208 228 208 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Crispin et al., 2008</xref>
###xml 230 249 230 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Nguyen et al., 2008</xref>
###xml 251 269 251 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Sakai et al., 2008</xref>
###xml 271 288 271 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Wong et al., 2008</xref>
###xml 408 411 408 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 208 215 <span type="species:ncbi:300214">Crispin</span>
Although the role of IL-17 and the Th17 pathway in lupus and Sjogren's syndrome is only beginning to be explored, several studies implicate a role for Th17 effector cells also in these autoimmune conditions (Crispin et al., 2008; Nguyen et al., 2008; Sakai et al., 2008; Wong et al., 2008). Furthermore, our data suggest that loss of IL-17 also suppresses development of exaggerated skin inflammation in Ro52-/- animals. Together, the present data link Ro52, an E3 ligase which targets many transcription factors in the IFN pathway, to disregulated proinflammatory cytokine production and to the development of tissue specific inflammation and systemic autoimmunity.
###end p 25
###begin title 26
MATERIALS AND METHODS
###end title 26
###begin title 27

###end title 27
###begin title 28
###xml 18 21 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Generation of Ro52-/- mice.
###end title 28
###begin p 29
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 781 784 781 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 832 835 832 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 843 846 843 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
###xml 877 882 <span type="species:ncbi:10090">mouse</span>
Ro52-/- mice were generated using standard gene targeting techniques. In brief, a short (1.7 kb) and a long (5 kb) arm were PCR cloned from the C57BL/6J BAC clone RP23-311N6 using the following primers: short arm, forward, 5'-ATCGATTGCAGAGGCAAAGCCATGGGAAAG-3', and reverse, 5'-ATCGATTCCTCCTCTCCAGCTCTGAGATCA-3'; and long arm, forward, 5'-GTCGACAGGCTACAACAGCTGTGCTCAGA-3', and reverse, 5'-GCGGCCGCACCCTGGCCTTGATTTCTAACAG-3'. They were then ligated into the gene targeting cassette vector pKS-TK-NeoloxP-IRES-GFP. The C57BL/6-derived embryonic stem cell line V26.2 was used for homologous recombination, and targeted embryonic stem cell clones were identified by Southern blotting and injected into BALB/c embryos. Chimeras carrying the target allele were bred to C57BL/6J mice. Ro52-/-p19-/- mice were generated by intercrossing Ro52-/- and p19-/- mice obtained from the Mutant mouse Regional Resource Center (). The study was approved by the Ethical Review Committee North, Stockholm County and Standing Committee on Animals at Harvard Medical School.
###end p 29
###begin title 30
Histochemistry and electron microscopy.
###end title 30
###begin p 31
###xml 533 534 529 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 188 194 <span type="species:ncbi:9986">rabbit</span>
###xml 229 232 <span type="species:ncbi:10116">rat</span>
###xml 295 298 <span type="species:ncbi:10116">rat</span>
###xml 1064 1070 <span type="species:ncbi:9793">donkey</span>
###xml 1076 1081 <span type="species:ncbi:10090">mouse</span>
Organs were fixed in 4% paraformaldehyde for 24 h, embedded in paraffin, and 4-5-microm sections stained with hematoxylin/eosin or Toluidine blue or were used in immunohistochemistry with rabbit polyclonal anti-GFP (Invitrogen), rat monoclonal anti-CD3 (clone SP7; Thermo Fisher Scientific), or rat monoclonal anti-B220 (clone RA3-6B2; BD). Antigen retrieval was performed using Retriever 2100 (PickCell Laboratories). For electron microscopy, small pieces of kidneys were further fixed in 2.5% glutaraldehyde and postfixed in 1% OsO4 plus 1% potassium ferrocyanide, followed by staining with 0.5% uranyl acetate. After dehydration, specimens were embedded in epoxy resin (agar 100) and cured by heat. 50-nm sections were contrasted with lead citrate and uranyl acetate and examined with an electron microscope (912AB; Carl Zeiss, Inc.) equipped with a MegaView III camera (Olympus) for digital image capture. Immunofluorescence staining of kidneys was performed on 7-microm paraformaldehyde-fixed sections of snap-frozen organs with an Alexa Flour 594-conjugated donkey anti-mouse IgG (Invitrogen).
###end p 31
###begin title 32
Cell isolation and flow cytometry.
###end title 32
###begin p 33
Single cell suspensions were prepared from lymphoid organs and cells blocked in Fc block (BD) for 30 min before staining by fluorophore-conjugated antibodies (BD). For intracellular cytokine staining, cells stimulated in vitro with soluble anti-CD3 were restimulated for 4 h with 50 ng/ml PMA (Sigma-Aldrich), 1 microg/ml ionomycin (Sigma-Aldrich), and 1 microl/ml GolgiStop (BD), followed by surface marker and intracellular cytokine staining according to the manufacturer's instructions. Cells were analyzed on a flow cytometer (BD).
###end p 33
###begin title 34
Serologic and proteinuria analyses.
###end title 34
###begin p 35
###xml 197 219 197 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Wermeling et al., 2007</xref>
###xml 466 481 466 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Wu et al., 2008</xref>
###xml 267 273 <span type="species:ncbi:9913">bovine</span>
###xml 302 306 <span type="species:ncbi:9913">calf</span>
Immunoglobulin isotype serum leves were analyzed using the SBA Clonotyping System/AP kit (SouthernBiotech), ANA by Hep-2 slides (Immuno Concepts), and anti-DNA antibodies, as previously described (Wermeling et al., 2007), in ELISA using plates coated with methylated bovine serum albumin and activated calf thymus DNA (Sigma-Aldrich). Lupus autoantigen microarrays were generated and used, as previously described, with 41 autoantigens spotted in replicates of six (Wu et al., 2008). Sera were diluted 1:50-1:100 in the assays. Proteinuria was detected using Multistix 5 (Bayer).
###end p 35
###begin title 36
Cytokine analysis by ELISA and quantitative RT-PCR.
###end title 36
###begin p 37
###xml 273 296 269 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Strandberg et al., 2008</xref>
Culture supernatants were collected after stimulation, as defined in each experiment, to assess cytokine production by ELISA or cytometric bead array (R&D Systems; BD). IFN-alpha was quantified by dissociation-enhanced lanthanide fluoroimmunoassay as previously described (Strandberg et al., 2008). RNA was extracted with RNeasy columns (QIAGEN) from cells ex vivo and analyzed by quantitative RT-PCR according to the manufacturer's instructions (Applied Biosystems) and expression related to HPRT.
###end p 37
###begin title 38
Oxazolone provocation.
###end title 38
###begin p 39
###xml 126 148 126 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Yokozeki et al. (2000)</xref>
###xml 150 154 <span type="species:ncbi:10090">Mice</span>
Oxazolone (4-ethozymethylene-2-phenyl-2-oxazolin-5-one) provocation was performed using the ear swelling test as described in Yokozeki et al. (2000). Mice were sensitized on shaved back skin with 150 microl of 0.3% Oxazolone (Sigma-Aldrich) dissolved in acetone/olive oil (4:1) applied on two consecutive days. 5 d later, the ears were challenged with 50 microl of a 0.1% Oxazolone solution on one ear and with the vehicle on the other. This was repeated on three consecutive days, and ear swelling was measured by a micrometer (Kroeplin). The whole procedure was repeated up to four times. Change in thickness was calculated by subtracting swelling caused by the vehicle.
###end p 39
###begin title 40
Ubiquitination assays.
###end title 40
###begin p 41
293T cells were transfected with 500 ng FLAG-IRF or FLAG-SMAD4, 500 ng Ro52-GFP, and 500 ng Myc-ubiquitin. The SMAD4 plasmid was a gift from C.-H. Heldin (Uppsala University, Uppsala, Sweden). 10 microM MG132 was added 28 h after transfection and cells were harvested 6 h later. Cells were lysed in immunoprecipitation buffer and, after clearing of the lysate, FLAG-M2-agarose beads (Sigma-Aldrich) were added, followed by incubation for 2 h. After washing, FLAG-IRFs were eluted with FLAG peptide (Sigma-Aldrich) and separated by SDS-PAGE, and ubiquitinated FLAG-IRFs were detected by immunoblotting against Myc (Santa Cruz Biotechnology, Inc.). FLAG-IRFs and GFP-Ro52 were detected in whole cell lysates by immunoblotting against FLAG (Sigma-Aldrich) and GFP (Sigma-Aldrich).
###end p 41
###begin title 42
Luciferase assays.
###end title 42
###begin p 43
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 218 225 218 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 585 592 585 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
For measurement of IRF activity, 105 293T cells were transfected in triplicates in 24-well plates using Fugene HD (Roche). Each well was transfected with 20 ng GAL4-IRF, 20 ng MycRo52 or empty Myc vector, 20 ng pRL-TK-Renilla, 20 ng pcDNA3.1-TLR9 or pFLAG-CMV1-TLR3 (gift from R. Medzhitov, Yale University, New Haven, CT; plasmids 13084 and 13091, respectively; Addgene), and 50 ng GAL4 reporter plasmid MH100-luc. After 16 h, cells were harvested and prepared for the reporter assay (Dual-Luciferase Reporter Assay system; Promega). Firefly luciferase luminescence was normalized to Renilla luminescence and used as a measure of IRF activity. Results are shown relative to transfections in which GAL4 was not fused to any IRF.
###end p 43
###begin title 44
Statistical analysis.
###end title 44
###begin p 45
###xml 116 117 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
Data are expressed as mean +/- SEM. Analysis of nonparametric data between groups was performed with a Mann-Whitney U test. Analysis, including repeated measures, was performed with an ANOVA mixed model, and a Fischer's exact test was used for analysis of frequencies between groups in small samples.
###end p 45
###begin title 46
Online supplemental material.
###end title 46
###begin p 47
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 108 111 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 249 252 249 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows expression of GFP as a reporter for Ro52. Fig. S2 shows lymphoid organization in Ro52+/+, Ro52+/-, and Ro52-/- mice. Fig. S3 shows leukocyte cell populations in naive mice. Fig. S4 shows autoantibody reactivity and splenomegaly in Ro52-/- mice. Online supplemental material is available at .
###end p 47
###begin title 48
Supplementary Material
###end title 48
###begin title 49
[Supplemental Material]
###end title 49
###begin p 50
We thank Nora Ramirez, Vijole Dzikaite, and Ann Tronnberg for skillful technical assistance, Mohamed Oukka for targeting vector design, Henrik Kallberg for statistical analyses, and Professor Carl-Henrik Heldin (Uppsala University, Uppsala, Sweden) for the gift of the SMAD4 plasmid.
###end p 50
###begin p 51
This work was supported by grants from the Swedish Research Council, the Swedish Foundation for Strategic Research, the Stockholm County Council, King Gustaf the Vth 80-year foundation, the Goran Gustafsson Foundation, the Torsten and Ragnar Soderberg Foundation, the Heart-Lung Foundation, Science Foundation Ireland, and the Swedish Rheumatism Association.
###end p 51
###begin p 52
The authors have no conflicting financial interests.
###end p 52
###begin article-title 53
###xml 35 40 <span type="species:ncbi:9606">human</span>
The emerging role of interferon in human systemic lupus erythematosus.
###end article-title 53
###begin article-title 54
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
###end article-title 54
###begin article-title 55
Immunopathogenesis of Sjogren's syndrome.
###end article-title 55
###begin article-title 56
###xml 36 44 <span type="species:ncbi:9606">patients</span>
Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.
###end article-title 56
###begin article-title 57
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.
###end article-title 57
###begin article-title 58
The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death.
###end article-title 58
###begin article-title 59
The autoantigen Ro52 is an E3 ligase resident in the cytoplasm but enters the nucleus upon cellular exposure to nitric oxide.
###end article-title 59
###begin article-title 60
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 58 63 <span type="species:ncbi:9606">human</span>
The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms.
###end article-title 60
###begin article-title 61
A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
###end article-title 61
###begin article-title 62
Structural organization and Zn2+-dependent subdomain interactions involving autoantigenic epitopes in the Ring-B-box-coiled-coil (RBCC) region of Ro52.
###end article-title 62
###begin article-title 63
The fellowship of the RING: the RING-B-box linker region interacts with the RING in TRIM21/Ro52, contains a native autoantigenic epitope in Sjogren syndrome, and is an integral and conserved region in TRIM proteins.
###end article-title 63
###begin article-title 64
The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3.
###end article-title 64
###begin article-title 65
The sequestosome 1/p62 attenuates cytokine gene expression in activated macrophages by inhibiting IFN regulatory factor 8 and TNF receptor-associated factor 6/NF-kappaB activity.
###end article-title 65
###begin article-title 66
Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages.
###end article-title 66
###begin article-title 67
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjogren's syndrome.
###end article-title 67
###begin article-title 68
###xml 105 111 <span type="species:ncbi:9606">humans</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice.
###end article-title 68
###begin article-title 69
Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome.
###end article-title 69
###begin article-title 70
Structural, functional and immunologic characterization of folded subdomains in the Ro52 protein targeted in Sjogren's syndrome.
###end article-title 70
###begin article-title 71
Targeting of the immune system in systemic lupus erythematosus.
###end article-title 71
###begin article-title 72
The tripartite motif family identifies cell compartments.
###end article-title 72
###begin article-title 73
The 52 000 MW Ro/SS-A autoantigen in Sjogren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.
###end article-title 73
###begin article-title 74
The type I interferon system in systemic lupus erythematosus.
###end article-title 74
###begin article-title 75
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18.
###end article-title 75
###begin article-title 76
Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus.
###end article-title 76
###begin article-title 77
Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies.
###end article-title 77
###begin article-title 78
Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus.
###end article-title 78
###begin article-title 79
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.
###end article-title 79
###begin article-title 80
Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.
###end article-title 80
###begin article-title 81
TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response.
###end article-title 81
###begin article-title 82
Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity.
###end article-title 82
###begin p 83
Abbreviations used: ANA, antinuclear antibody; IRF, IFN regulatory factor; SLE, systemic lupus erythematosus; TLR, toll-like receptor.
###end p 83

